Suppression of cytochrome P450 gene expression in the livers of mice with concanavalin A-induced hepatitis

European Journal of Pharmacology

Volumn 394, Issue 1, 2000, Pages 157-161

  Okamoto, Toshihiro ^a  

^a Nippon Chemiphar Co Ltd   (Japan)

Author keywords

Concanavalin A; Cytochrome P450; Hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; CONCANAVALIN A; CYTOCHROME P450; CYTOCHROME P450 3A; GADOLINIUM CHLORIDE; PHENACETIN O DEETHYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEPATITIS; IMMUNITY; KUPFFER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CONCANAVALIN A; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GADOLINIUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATITIS, TOXIC; LIVER; MICE; MICE, INBRED BALB C;

EID: 0034615937     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00134-5     Document Type: Article

References (12)

1. Abdel-Razzak Z., Loyer P., Fautrel A., Gautier J.C., Corcos L., Turlin B., Beaune P., Guillouzo A. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44:1993;707-715.
2. Armstrong S.G., Renton K.W. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice. Mol. Pharmacol. 43:1993;542-547.
3. Chang K.C., Lauer B.A., Bell T.D., Chai H. Altered theophylline pharmacokinetics during acute phase respiratory viral illness. Lancet. 1:1978;1132-1133.
4. Gantner F., Leist M., Lohse A.W., German P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice. The role of tumor necrosis factor. Hepatology. 21:1995;190-198.
5. George J., Liddle C., Murray M., Byth K., Farrell G.C. Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem. Pharmacol. 49:1995;873-881.
6. Ghezzi P., Saccardo B., Bianchi M. Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem. Biophys. Res. Commun. 136:1986;316-321.
7. Guengerich F.P., Turvy C.G. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256:1991;1189-1194.
8. Hardonk M.J., Dijkhuis F.W.J., Hulstaert C.E., Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukocyte Biol. 52:1992;296-302.
9. Okamoto T., Furuya M., Yamakawa T., Yamamura K.-I., Hino O. TNF-α gene expression in the liver of the IFN-γ transgenic mouse with chronic active hepatitis. Biochem. Biophys. Res. Commun. 226:1996;762-768.
10. Okamoto T., Maeda O., Tsuzuike N., Hara K. Effect of gadolinium chloride treatment on concanavalin A-induced cytokine mRNA expression in mouse liver. Jpn. J. Pharmacol. 78:1998;101-103.
11. Renton K.W. Factors affecting drug biotransformation. Clin. Biochem. 19:1986;72-75.
12. Stanley L.A., Adams D.J., Lindsay R., Meehan R.R., Liao W., Wolf C.R. Potentiation and suppression of mouse liver cytochrome P450 isozymes during the acute phase response induced by bacterial endotoxin. Eur. J. Biochem. 174:1988;31-36.